NEWS

Jul 22, 2014
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014

Jul 21, 2014
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386

Jul 02, 2014
Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc.

Jun 02, 2014
Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy


EVENTS

Q2 2014 Jazz Pharmaceuticals Earnings Conference Call
Aug 05, 2014

Jazz Pharmaceuticals Agreement to acquire rights to defibrotide in the Americas
Jul 02, 2014

Jazz Pharmaceuticals at Goldman Sachs Healthcare Conference
Jun 10, 2014

Jazz Pharmaceuticals Conference Call at 2014 SLEEP Meeting
Jun 02, 2014

Jazz Pharmaceuticals at UBS Global Healthcare Conference
May 20, 2014

Q1 2014 Jazz Pharmaceuticals Earnings Conference Call
May 08, 2014

Jazz Pharmaceuticals at Barclays Healthcare Conference
Mar 12, 2014

Jazz Pharmaceuticals at Cowen Health Care Conference
Mar 05, 2014

Q4 2013 Jazz Pharmaceuticals Earnings Conference Call
Feb 25, 2014

Jazz Pharmaceuticals at JPMorgan Healthcare Conference
Jan 13, 2014

Jazz Pharmaceuticals Conference Call to discuss Rights to ADX-N05 Acquisition from Aerial Biopharma
Jan 13, 2014

Jazz Pharmaceuticals Conference Call to discuss its Definitive Agreement to Acquire Gentium S.p.A
Dec 19, 2013

Jazz Pharmaceuticals at Piper Jaffray Healthcare Conference
Dec 03, 2013

Jazz Pharmaceuticals at Credit Suisse Healthcare Conference
Nov 12, 2013

Q3 2013 Jazz Pharmaceuticals Earnings Conference Call
Nov 05, 2013

Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients’ lives. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success.

NEW: BREAKING GROUND IN IRELAND

Jazz Pharmaceuticals has commenced construction of a manufacturing and development facility in Ireland

Read more

NEW: PRODUCT UPDATE

Jazz Pharmaceuticals and Gentium Announce European Commercial Launch of First Approved Life-saving Treatment for Severe Hepatic Veno-Occlusive Disease

Read more

MEDICINE ABUSE PROJECT

As part of our commitment to patient and public safety, we’re proud to be supporting the Medicine Abuse Project.

Visit the Medicine Abuse Project site

NEW: PRODUCT UPDATE

Jazz Pharmaceuticals plc
announced U.S. commercial
availability of the newest
product in its psychiatry
portfolio.

Read more